IMARI 2026 | PACE speak at panel discussion

Programme Director, Dr Beverley Isherwood, will be speaking on behalf of PACE at IMARI 2026. She will join other top scientists, innovators, and cross-sector leaders at the forefront of the fight against antimicrobial resistance. This dynamic meeting explores the full innovation pipeline – from uncovering emerging resistance mechanisms to advancing next-generation therapeutics and accelerating translation into clinical studies.

Friday 30 January 2026

Meet the Expert: Non-Dilutive Push Funding: CARB-X, Gram-Negative Antibiotic Discovery Innovator, BARDA
Moderators: Erin Duffy Ph.D., Gates Foundation; Patricia Bradford, Ph.D., Antimicrobial Development Specialists, LLC

• 7:30–8:45 a.m. | Panel Discussion
  Speakers: Su Chiang, Ph.D., CARB-X; Beverley Isherwood, Ph.D., PACE; Erin Duffy Ph.D., Gates Foundation

We are in a race against biology. Bacteria and other microbes are evolving faster than our scientific discoveries and, up until now, the speed of developing new diagnostics and treatments has been too slow. We have a chance to change that. The answer is PACE. PACE is a new approach to tackling one of our most complex health challenges – AMR.

At IMARI 2026, hear about PACE work with the AMR community to help progress early-stage antimicrobial drug and diagnostic projects with greater speed, support and confidence – giving the best AMR innovations the greatest chance of success. Find out about the projects PACE is investing in that address the world’s most threatening pathogens. And how PACE will support these projects to deliver innovations for onward development and investment, moving them closer to clinical trials. PACE is working together with the brightest and best to help tackle this rising threat to global health.

Join us in Las Vegas, January 28-30, 2026, to advance cutting-edge science, spark bold ideas, and forge powerful global partnerships.